Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jonathan S. Abramowitz is active.

Publication


Featured researches published by Jonathan S. Abramowitz.


Behavior Therapy | 2000

Effects of comorbid Depression on response to treatment for obsessive-compulsive disorder

Jonathan S. Abramowitz; Martin E. Franklin; Gordon P. Street; Michael J. Kozak; Edna B. Foa

We examined the effects of comorbid depression on response to treatment for obsessive-compulsive disorder (OCD) using cognitive-behavioral therapy with and without medication. Eighty-seven OCD patients were divided into nondepressed and mildly, moderately, and severely depressed groups on the basis of their pretreatment Beck Depression Inventory (BDI) scores. Each received an intensive cognitive-behavioral treatment program involving exposure with response prevention (EX/RP); 59 (68%) were also taking medication for OCD. Patients with severe initial depression (BDI ≥30) showed significantly less improvement compared to those less depressed or nondepressed; yet, even highly depressed patients showed moderate treatment gains. Failure to habituate to anxiety-evoking stimuli during exposure and a lack of motivation for therapy are considered possible causes of attenuated outcome.


Behavior Therapy | 2000

Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD

Jonathan S. Abramowitz; Edna B. Foa

Studies that have examined the effects of comorbid depression on response to treatment in obsessive-compulsive disorder (OCD) have yielded inconsistent results. We examined treatment outcome for 15 OCD patients with comorbid major depressive disorder (MDD) and 33 OCD patients without MDD. All patients received intensive cognitive-behavioral therapy by exposure and response (ritual) prevention. Improvement in OCD symptoms was observed in both patient groups, and treatment gains were maintained at follow-up. Whereas the presence of a comorbid MDD diagnosis in OCD was not related to treatment failure, nondepressed patients had significantly lower posttreatment and follow-up OCD severity scores.


Professional Psychology: Research and Practice | 2002

Cognitive-Behavioral Therapy With and Without Medication in the Treatment of Obsessive-Compulsive Disorder

Martin E. Franklin; Jonathan S. Abramowitz; Donald A. Bux; Lori A. Zoellner; Norah C. Feeny

Cognitive–behavioral therapy (CBT) and pharmacotherapy with serotonin reuptake inhibitors (SRIs) are established monotherapies for obsessive–compulsive disorder (OCD), yet research on their combined efficacy is lacking. Practicing psychologists who treat OCD are thus unable to say definitively whether exposure and ritual prevention would be more successful with concomitant SRI pharmacotherapy. The authors explored this issue in a clinical sample of 56 outpatients who received fee-for-service CBT; 31 (55%) received CBT alone, and 25 (45%) received CBT plus SRI. Both groups made clinically significant and comparable posttreatment gains, suggesting that CBT is effective with or without concomitant pharmacotherapy. Clinical implications are discussed. With the current widespread use of medication to treat a variety of mental health problems, professional psychologists often need to discuss with prospective patients the pros and cons of continuing the medication regimen while undergoing psychotherapy. Conversely, patients who are considering medication may ask their psychologists whether they should do so while receiving psychological services to maximize benefit. Unfortunately, the answers to these questions are often unclear, as research on the relative efficacy of psychotherapy, pharmacotherapy, and their combination is underdeveloped for most psychological disorders. This is certainly the case with obsessive compulsive disorder (OCD), for which the efficacy of cognitive behavior therapy (CBT) and pharmacotherapy with serotonin reuptake inhibitors (SRIs) has been well established (see Abramowitz, 1997; Greist, Jefferson, Kobak,


Journal of Anxiety Disorders | 1999

Health Concerns in Patients With Obsessive-Compulsive Disorder

Jonathan S. Abramowitz; Bartholomew D. Brigidi; Edna B. Foa

In the present study, individuals with obsessive-compulsive disorder (OCD) who also had excessive health concerns (n = 56) were compared with OCD individuals without such concerns (n = 343) regarding their OCD symptom severity, types of obsessions and compulsions, insight into the irrationality of their obsessions, and prevalence of generalized anxiety disorder. While the presence of health concerns did not affect the severity of OCD symptoms, the groups differed with respect to the types of symptoms displayed: those with health concerns had more somatic and harm obsessions, and checking compulsions: whereas those without such concerns had more contamination obsessions and washing compulsions. The insight of both groups ranged from poor to excellent, yet the number of individuals with poor insight was greater among those with health concerns than those without. Generalized anxiety disorder was also more prevalent among OCD individuals with excessive health concerns.


Journal of Consulting and Clinical Psychology | 2000

Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.

Martin E. Franklin; Jonathan S. Abramowitz; Michael J. Kozak; Jill T. Levitt; Edna B. Foa


Behaviour Research and Therapy | 2001

Memory and memory confidence in obsessive-compulsive disorder.

David F. Tolin; Jonathan S. Abramowitz; Bartholomew D. Brigidi; Nader Amir; Gordon P. Street; Edna B. Foa


Behavior Therapy | 1999

Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder

Edna B. Foa; Jonathan S. Abramowitz; Martin E. Franklin; Michael J. Kozak


Psychotherapy Research | 2003

A naturalistic examination of therapist experience and outcome of exposure and ritual prevention for OCD

Martin E. Franklin; Jonathan S. Abramowitz; Jami M. Furr; Sarah A. Kalsy; David S. Riggs


The behavior analyst today | 2001

Recent Developments in the Cognitive-Behavioral Treatment of Obsessive-Compulsive Disorder

Jonathan S. Abramowitz; Sarah A. Kalsy


Archive | 2015

Integrating OCD: Perspectives from Five Empirically Supported Approaches

Maureen L. Whittal; Roz Shafran; Jonathan S. Abramowitz; Michael P. Twohig; Dennis Tirch; Michael Kyrios

Collaboration


Dive into the Jonathan S. Abramowitz's collaboration.

Top Co-Authors

Avatar

Edna B. Foa

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gordon P. Street

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maureen L. Whittal

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Roz Shafran

University College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge